One of the hallmarks of Alzheimer’s disease is the formation of amyloid plaques—sticky clumps of a protein called amyloid beta—that collect between neurons in the brain. Increasingly, however, ...
Chemists use peptides from Alzheimer’s and Type II diabetes to describe five new rippled beta-sheets
In the 1950s, Linus Pauling and Robert Corey proposed the idea of rippled beta-sheets — sections of proteins— called peptides— that are mirror-images of each other, held together by hydrogen bonds in ...
Though there is so much to learn about the way Alzheimer's develops in the human brain, amyloid beta proteins have long been implicated in its advance. A new study has uncovered a previously unknown ...
New York researchers have taken another step in the lengthy battlle against Alzheimer’s disease, finding a way to slow memory ...
Amyloid-beta (A-beta) aggregates are tangles of proteins most notably associated with neurodegenerative diseases like Alzheimer's. Despite its constant stint in the limelight, however, researchers ...
A new study from Cold Spring Harbor Laboratory Professor Nicholas Tonks, graduate student Yuxin Cen, and postdoctoral fellow ...
Their study, published in a leading scientific journal, shows that blocking a protein called PTP1B can improve learning and ...
Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about ...
People with type 2 diabetes are at increased risk of Alzheimer's disease and other adverse cognitive health issues. A new study conducted at by Umeå University, Sweden, shows that the reason for the ...
Amyloid immunotherapies took 20 years to reach the clinic. Scientists are testing new types of therapies they hope could deliver stronger benefits and fewer side effects On a spring day in 2011, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results